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Abstract
Background: There is a need to ensure that the risks associated with medication 
usage in primary health care are controlled. To maintain an understanding of the 
risks, health- care organizations may engage in a process known as “mindful organiz-
ing.” While this is typically conceived of as involving organizational members, it may 
in the health- care context also include patients. Our study aimed to examine ways in 
which patients might contribute to mindful organizing with respect to primary care 
medication safety.
Method: Qualitative focus groups and interviews were carried out with 126 mem-
bers of the public in North West England and the East Midlands. Participants were 
taking medicines for a long- term health condition, were taking several medicines, had 
previously encountered problems with their medication or were caring for another 
person in any of these categories. Participants described their experiences of dealing 
with medication- related concerns. The transcripts were analysed using a thematic 
method.
Results: We identified 4 themes to explain patient behaviour associated with mindful 
organizing: knowledge about clinical or system issues; artefacts that facilitate control 
of medication risks; communication with health- care professionals; and the relation-
ship between patients and the health- care system (in particular, mutual trust).
Conclusions: Mindful organizing is potentially useful for framing patient involvement 
in safety, although there are some conceptual and practical issues to be addressed 
before it can be fully exploited in this setting. We have identified factors that influ-
ence (and are strengthened by) patients’ engagement in mindful organizing, and as 
such would be a useful focus of efforts to support patient involvement.
K E Y W O R D S
high-reliability organizing, medication safety, mindful organizing, organizational safety, 
patient safety, primary care
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1  | BACKGROUND
Medicines can prevent or treat many conditions and so are the most 
common intervention in health care, with over 1 billion prescription 
items being issued in English primary care each year.1 The increasing 
prevalence of long- term or multiple health conditions managed in the 
community2 and a trend towards greater integration between pri-
mary and secondary care services3 mean that primary care makes an 
important contribution to population health. It also means, though, 
that medicines management in this setting is increasingly high- risk, 
with hazards including the supply of inappropriate medication and 
insufficient monitoring of medicines usage.4 Epidemiological data 
from the United Kingdom suggest a prevalence of approximately 5% 
for potentially hazardous prescribing and between 7% and 11% for 
omitted monitoring,5,6 while a systematic review7 estimated a me-
dian prevalence of 13% for harmful adverse drug events in North 
American, European and Australian ambulatory care. Hence, there 
is benefit in identifying ways of improving primary care medication 
safety. Amongst the issues that have been explored is the role of 
patients, their carers and their representatives in ensuring safe prac-
tice, but while there is a prima facie argument for involving health- 
care service users, it remains unclear how—and to what extent—they 
can make an effective contribution to patient safety.8 One source 
of insights about patient safety, which might be addressed to the 
issue outlined here, is the research on safety across different work 
settings.9 In this study, we examine how one theory that has been 
applied to organizational safety can be used to understand patient 
involvement in medication safety.
1.1 | Mindful organizing and patient safety
High- reliability theory10,11 attempts to characterize what organiza-
tions that avoid failure in high- risk activities do to maintain reliability. 
According to Weick & Sutcliffe,11 so- called high- reliability organiza-
tions (HROs) demonstrate particular characteristics in the way they 
operate: anticipating problems (being aware of what is happening 
in the work system; being alert to ways in which an incident could 
occur; looking beyond simplistic explanations for incidents); and 
containing problems (being prepared to deal with contingencies; 
using relevant expertise regardless of where it is situated within the 
organizational hierarchy). Vogus & Sutcliffe12 proposed “mindful or-
ganizing” as a collective mental orientation in which the organization 
continually engages with its environment, reorganizing its structures 
and activities as necessary, rather than mindlessly executing plans 
in ignorance of the prevailing circumstances. This is a dynamic so-
cial process, consisting of specific actions and interactions between 
those engaged in frontline organizational work. It creates the con-
text for thought and behaviour across the organization, but is rela-
tively transient and so needs to be actively maintained.11
The extent to which high- reliability theory applies to organiza-
tional safety in general, and patient safety in particular, has been the 
subject of some debate.13,14 Leveson et al15 noted that high- reliability 
theory was based on a specific type of organization—one in which 
the work system is relatively stable and its characteristics well un-
derstood—and argue that it is not generalizable to others. They fur-
ther argue that reliability and safety are not necessarily equivalent 
or even compatible properties of a work system; therefore, high- 
reliability theory is less applicable to safety than has been assumed. 
However, Hollnagel16,17 and Sujan et al18 conceive of safety in terms 
of resilience—an organization’s capacity to maintain successful work 
in the face of varying conditions. Hollnagel attributes resilience to 
an organization’s mindfulness (in Weick’s sense of the term), thus 
implying a link between high- reliability theory and organizational 
safety. Similarly, Hopkins19 argues that the characteristics of a HRO 
and the components of safety culture suggested by Reason20 (re-
porting; flexibility; learning; fairness) are broadly equivalent. As for 
empirical data, Roberts et al21 demonstrated the benefit for patient 
outcomes of a paediatric intensive care unit adopting high- reliability 
principles, while Vogus & Sutcliffe22 examined the relationship be-
tween mindful organizing and patient safety using a survey of nurses 
in the United States. The latter study found a negative relationship 
between the level of mindful organizing and the number of reported 
medication errors and patient falls.
While there appears to be convergence between the various con-
cepts described here (i.e. high- reliability organizing, resilience and 
safety culture), a particular insight offered by the literature on mind-
ful organizing is to emphasize its grounding in social relations.23-25 In 
other words, the collective capacity to understand, anticipate and 
respond to problems both depends on and subsequently provides 
a structure for social interactions such as collaboration and negoti-
ation.23,26 The potential relevance of this insight to patient safety is 
demonstrated by examining the issue of patient involvement.
1.2 | Patients’ contributions to medication safety
Previous research suggests that patients could be involved in the 
prevention of safety issues.27-30 Roles for patients include reporting 
adverse events, notifying or questioning health- care professionals in 
the case of any concerns, and providing relevant information about 
their medicines or health conditions.31-35 Yet, involving patients in 
safety is not necessarily a straightforward matter. First, involvement 
occurs in the context of a relationship between patients and health- 
care professionals, such that patients feel more inclined to involve 
themselves when they perceive that they will be treated with re-
spect and their contributions heard and taken seriously.36-38 Indeed, 
a study of patients’ perceptions about threats to safety39 found that 
a breakdown in the relationship between patient and clinician was 
a more prevalent concern than was a technical error such as an ad-
verse drug event, despite the latter typically being the main concern 
of health- care professionals. A second issue is that patients’ involve-
ment is informed by their understanding of the problem at hand. 
Patients vary in their belief that safety is a priority in their care, or 
even a distinct issue (as opposed to being an assumed part of their 
care); they also draw upon accumulated knowledge and experience 
about their care in deciding whether and how to act.37,40,41 Third, 
patients will be more inclined to become involved in safety activities 
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if they perceive that they have the capacity and means to do so and 
that doing so will have a positive effect.8,37,41
From a mindful organizing perspective, patient involvement 
might be conceptualized as a set of interactions between patients 
and health- care professionals that maintain collective “mindfulness” 
about safety issues, that is an awareness of potential or impending 
patient safety hazards and a capacity for acting on such insights.14 
Through these interactions, patients and their families or carers can 
contribute to mindfulness by amplifying otherwise weak signals of 
patient safety problems, questioning issues that would otherwise 
be taken for granted, and raising concerns that would otherwise be 
missed. Table 1 describes some examples of potential contributions 
that follow from the elements of mindful organizing listed by Weick 
et al.11,42
Given its apparent relevance to patient safety, our study aimed 
to examine ways in which patients might contribute to mindful orga-
nizing. To do so, we drew from primary care patients’ experiences of 
dealing with medication safety issues.
2  | METHOD
2.1 | Design and sampling
The study used a qualitative design. The sampling frame was mem-
bers of the public in North West England and the East Midlands who 
either had a long- term health condition requiring medicines usage, 
were taking several medicines, had previous experience of problems 
with their medicines or were carers of people in any of these groups. 
This frame was chosen on the basis of evidence that patients with 
long- term conditions or on multiple medications are at increased 
risk of medication- related problems.43 We identified members of 
the frame in 3 ways: (i) a list of people who had previously expressed 
interest in patient safety research at our institution; (ii) radio, print 
and social media advertisements; and (iii) local community organi-
zations who assisted with recruitment (e.g. patient advocacy and 
cultural groups). Recruitment was on an opt- in basis, with partici-
pants receiving a gift voucher and travel expenses in return for 
taking part. Ethical approval for the study was obtained from the 
National Health Service Research Ethics Committee (reference 13/
LO/1531) and The University of Nottingham Medical School Ethics 
Committee.
2.2 | Data collection
Data were collected primarily through focus groups. The size of 
each group ranged from 3 to 11 participants, depending on par-
ticipant availability. One- to- one interviews were conducted with 
participants who were unable to attend a focus group. Each focus 
group or interview was led by one member of the research team 
(DLP, SG, PJL, KM or NS), with another member of the research 
team, or a layperson from our research group’s public and patient 
involvement panel, acting as a cofacilitator. Three focus groups 
were conducted for participants who did not speak English as a 
first language: 1 in Urdu; 1 in Hindi; and 1 in British Sign Language 
(BSL). For the Urdu and Hindi groups, a researcher who was flu-
ent in the respective language acted as the lead facilitator, with a 
member of the research team as cofacilitator. The third group was 
facilitated by DLP with a BSL interpreter external to the research 
team acting as cofacilitator.
A semi- structured topic guide was used to guide each discus-
sion. This included the following topics: problems that participants 
had experienced with medicines; their interactions with doctors and 
pharmacists; their own contribution to safe medication use; their 
knowledge of medication reviews; and adverse event reporting. 
Each session lasted for between 75 and 120 minutes and, with the 
consent of all participants, was audio- recorded and transcribed.
TABLE  1 Examples of patients’ contribution to mindful organizing
Element Definition
Example of patient 
contribution
Preoccupation with failure Being constantly aware of the potential for an unexpected event 
that could compromise patient safety
Querying the substitution of 
prescribed medication by a 
pharmacist
Reluctance to simplify medication 
interpretations
Questioning assumptions and received wisdom to create a more 
complete and nuanced understanding of risks
Cross- checking different 
sources of advice (eg doctor; 
medicines literature)
Sensitivity to operations On- going interaction and information sharing about human and 
organizational factors that are influencing the current safety level
Highlighting specific communi-
cation needs and suggesting 
ways of providing for these 
needs
Commitment to resilience Maintaining a capability to detect, contain, recover and learn from 
an adverse event before it causes further harm
Identifying a medication error 
and discussing the error with 
health- care professionals
Deference to expertise When dealing with a problem, allowing decisions to be made by 
those with the most expertise, regardless of formal role
Where capable, engaging in 
shared decision making about 
medication usage
Definitions adapted from Vogus & Sutcliffe.12
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2.3 | Data analysis
The transcripts were analysed using an inductive thematic ap-
proach.44 Initially, the focus of the analysis was on instances of pa-
tients being involved, or attempting to be involved, in patient safety 
activities. Four members of the research team (DLP, SG and PJL and 
KM) separately reviewed the same 3 transcripts within the data set 
to identify emerging themes related to patient involvement. The re-
search team members then discussed and agreed on a set of themes 
that appeared to distinguish between the successful and unsuccess-
ful attempts at involvement described by participants. These themes 
were subsequently applied across the whole data set by 3 of the 
researchers (DLP, SG and PJL). When comparing the participants’ 
accounts, the first author, who was familiar with safety science re-
search, noted that the accounts varied in the extent to which they 
demonstrated the elements of mindful organizing listed in Table 1. 
Therefore, literature on this topic was used to inform interpreta-
tion of the themes. Finally, the findings were reviewed by the other 
members of the research team (TA, DA, MJ and NS) to ensure that 
they adequately reflected both the content of the transcripts and 
the research question. Version 10 of NVivo was used to document 
the analysis.
3  | FINDINGS
A total of 126 participants took part in a focus group or interview. 
Table 2 shows the type and number of patients in each session. We 
identified 4 themes that explained patients’ contributions to mindful 
organizing: knowledge; communication; artefacts; and relationships.
3.1 | Knowledge
Participants’ accounts referred to their assimilating and using knowl-
edge, either about the clinical indication for their medication use or 
about the system within which their medicines were supplied. Some 
participants—typically those with long- term or complex medica-
tion needs—described having learned about the need to ensure that 
medication safety risks are properly managed during their interac-
tions with health- care organizations.
[I have] an allergy to Penicillin, so [I have] to look for that 
word on [the label] to make sure it’s not inside. [But] in an 
emergency, if I was to go to the hospital [for example, the 
staff] don’t know that I’ve got this allergy, it’s not on their 
records, I have to tell them directly [about it] so they don’t 
give [Penicillin to] me.  [Deaf group]
On a number of occasions I’ve had to be careful that [the 
pharmacist doesn’t] give [me] something that’s the near-
est substitute [for a branded product]. […] When I was 
on ciclosporin [and tacrolimus], [the pharmacist said] […] 
“we can’t get [those], [instead] we’re going to get you [ge-
nerics]” […] [I said] “no you’re not.” […] The dosage needs 
to be changed with the different type, and […] I know of 
cases where patients have become seriously ill because 
of that.  [Renal conditions group]
The insights of these “expert patients,” gained from personal 
or vicarious experience, seemed to provide them with a basis 
for playing a proactive role in medication safety. With regard to 
mindful organizing, both demonstrate a preoccupation with fail-
ure, being concerned to ensure that they do not receive inappro-
priate medication. In addition, the second participant describes a 
reluctance to simplify interpretations, in that he draws the phar-
macists’ attention to a source of risk they may otherwise overlook. 
However, being an experienced medication user was not always 
a sufficient safeguard against medication- related problems. One 
participant describes how, despite taking precautions with her 
medication usage, she was affected by a medication hazard of 
which she was unaware.
TABLE  2 Participants in the study
Participant type N
Focus groups
Generic patient group
Session 1 11
Session 2 7
Session 3 11
Session 4 9
Parents of children with a long- term condition 4
Renal patients 8
Cardiovascular patients
Session 1 10
Session 2 9
Mental health service users
Session 1 3
Session 2 7
People recovering from substance misuse 6
Members of a male- to- female transgender group 3
Members of a Deaf group (BSL speakers) 6
Members of a visually impaired group 3
Elders
White (Session 1) 3
White (Session 2) 3
Black Afro- Caribbean 9
Asian (Urdu speakers) 8
Asian (Hindi speakers) 4
Interviews
Carer of a mental health patient 1
Visually impaired service user 1
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My psychiatrist was on holiday, so I [saw] this locum and 
he [suggested] changing my medication. I [said] okay. I’d 
also gone to the [GP] because I was ill, and they [gave] 
me antibiotics. I knew that because I’d taken antibiotics 
I can’t take the cholesterol tablets and I have to lower 
the dose of my warfarin. But what nobody told me was 
the antibiotics and the tablets for my mental health, 
you can’t take them together because the effect of it 
may make you absolutely [incapacitated]. It was awful. 
 [Mental health group]
While this participant also demonstrates a preoccupation with fail-
ure, its effect is constrained by her lack of knowledge about one source 
of failure (the unrecognized interaction hazard). Recognizing and at-
tempting to mitigate the fragmented nature of the prescribing—carried 
out by different health- care professionals in different locations, pos-
sibly with a limited understanding of the overall clinical picture—may 
have also led to an awareness of the additional hazard, thus demon-
strating the effect of sensitivity to operations. These observations 
suggest that, similarly to the argument cited earlier,23,26 participants’ 
knowledge both informs and is informed by mindful organizing.
3.2 | Communication
The experience of the mental health patient highlights the interac-
tive nature of mindful organizing; in that instance, the patient’s work 
in preventing an adverse event assumed that the health- care profes-
sionals recognized and informed her about relevant sources of risk. 
In our study, communication between patients and health- care pro-
fessionals was often mentioned in relation to patients’ involvement 
in medication safety activities.
When I asked [the pharmacist] what these tablets were 
they took me into a room and told me everything I needed 
to know. Because I kept [asking the doctor] “why am I on 
three [different] blood pressure tablets?” They were for 
different things.  [Long-term conditions group]
I phoned [the practice] and said, I’m [already] on this 
medication, and [was then prescribed] some vitamin A, 
[but] according to the [information leaflet I] mustn’t take 
it. [The receptionist] said, “well just don’t take it [and] 
don’t worry about it then,” which is [the GP’s] normal an-
swer anyway.  [Visually impaired group]
These accounts differ in the degree to which the communication 
led to an improvement in knowledge about the patient’s medication. 
In the first instance, the pharmacist responded to the patient by 
helping to educate him about his medication. In the second, the pa-
tient was alerted to a potential risk by the information leaflet, but he 
gained no further knowledge from his attempt to discuss it—and it is 
not clear whether his GP gained any further insight about the patient’s 
medication needs either. What both accounts do have in common is 
that they illustrate patients engaging in mindful organizing (in both 
cases, demonstrating a reluctance to simplify interpretations) in an 
attempt to compensate for knowledge gaps left by the health- care 
professionals.
3.3 | Artefacts
The physical artefacts involved in medicines management provide 
further ways to support mindful organizing. As suggested in the pre-
vious example, medication labels and information leaflets provided 
a standardized source of knowledge about medicines, which alerted 
several of the participants to potential medication risks. In doing so, 
they facilitated a preoccupation with failure and a reluctance to sim-
plify operations.
I said to the GP, “am I allowed to take [these tab-
lets], because […] I’ve had a transplant?” He went, 
“oh yes, you can take them.” I got them home and […] 
read the leaflet [which] said, do not take. So, I [rang] 
the hospital, [who] said [definitely] do not take them. 
 [Renal conditions group]
However, it was evident from the data that medication labels and 
leaflets were used inconsistently across the sample. One barrier that 
affected some of the participants was a lack of accessibility, due to ei-
ther the format (in the case of the visually impaired group) or language 
difficulties (in the case of the hearing- impaired and Asian elder groups). 
From a mindful organizing perspective, these problems highlight the 
value of sensitivity to operations, which would facilitate patients and 
health- care professionals to collaborate in addressing the communica-
tion needs of the former.
If you are blind or partially sighted how do you read your 
medication label if you don’t read braille? Because a lot of 
people assume that the braille on packaging is the detail, 
but it isn’t, it’s the product. So when the pharmacist puts 
a sticky label on the packet for the individual, if you can’t 
see that label, which is virtually anybody who is sight im-
paired, then actually how are they going to be compliant? 
 [Visually impaired group]
For those who were more easily able to access information leaf-
lets, a further barrier was finding them to be uninformative. This 
too might be understood as a challenge to mindful organizing, for 
which patients might compensate through a reluctance to simplify 
operations.
You can’t actually rely on those information leaflets in 
the box because sometimes there is stuff that has been 
updated or different manufacturers have done different 
tests. […] I looked at the […] internet and found extra in-
formation from […] either the manufacturer or things like 
6  |     PHIPPS et al.
the NHS website. So that it’s more than just reading the 
print out that you get at the time.  [Renal conditions 
group]
Other aspects of physical design—for example colour—may also 
serve to inform patients about their medication and help them to iden-
tify any anomalies. However, participants’ accounts suggest that, as 
with labels and leaflets, physical features vary in their informational 
value. For example, some patients, but not others, are able to use co-
lour as a reliable guide to identifying their medication.
I checked my insulin when I got it and [noticed that] they 
had written on the [container] the right [name]—Levemir, 
which is [what] I take—[but] it had like an orange thing 
on it and I thought, oh that’s [unusual]. […] It [turned out 
to be] the right make […] but it was the wrong strength. 
 [Cardiovascular conditions group]
Because of the medication I’m on, if I take antibiotics I’m 
not allowed to take the cholesterol tablets, but I just have 
to guess I’m throwing away the right one, because it used 
to be orange, and now they’re white. And I take other 
white tablets of an evening.  [Mental health group]
Both accounts illustrate how a commitment to resilience may be 
present in, or absent from, the design and supply of medicinal prod-
ucts. Furthermore in the second example, the mindlessness that is 
represented in the medication’s colour- coding is compounded by an 
apparent lack of compensatory mindfulness on the part of the patient, 
who might otherwise demonstrate a sensitivity to operations by raising 
the problem with those involved in medication supply.
3.4 | Relationships and trust
Implicit to all of the participants’ accounts is a common theme: their 
trust in the health- care system. There are a number of ways in which 
trust appears to operate. In some cases, the participants suggested a 
relatively high level of trust in the system to work as they expected 
(eg when assuming that health- care professionals would detect and 
communicate all prescribing hazards). In others, the participants sug-
gested a relatively low level of trust (eg when doubting how seri-
ously one’s concerns about medication are being taken by the GP). 
The participant’s trust could be appropriately placed (eg if medicines 
information sought from a GP or pharmacist is correct) or inappro-
priately placed (eg if medication is misidentified). Some participants 
referred to the use of “trusted” collaborators or aids, which varied in 
terms of their formality and their degree of improvisation.
I went into [the pharmacy] and said, “I can’t read my 
medication label, I believe that there is such a thing as a 
talking label.” [Fortunately] I got a really proactive phar-
macist [who went to] find out about it. [So] they stick the 
printed label on as usual, and then the pharmacist goes 
out the back and verbally dictates what’s on the label. 
 [Visually impaired group]
[I was once prescribed] Penicillin, even though I am aller-
gic to [it]. [My daughter- in- law] saw it and said “you can’t 
take that.” I always let my daughter- in- law check the 
medicine first. She said that if she hadn’t checked [that 
one], then I would have had to be taken to the hospital. 
 [Asian elders group]
In principle, the measures adopted by these participants serve 
to mitigate the risks associated with medication usage. From a 
mindful organizing point of view, they result from sensitivity to op-
erations involving the participants and they contribute to resilience 
in the patients’ medication usage. However, they may not always 
offer as reliable a risk control as those involved assume. For exam-
ple, in the second example, the safety of the arrangement depends 
on the mediator’s ability to detect any hazards that are present.
While the foregoing examples highlight the patient’s level and 
focus of trust, another variable in patient interactions with health- 
care professionals is the degree of trust that the health- care profes-
sionals have in patients. As the following excerpts show, perceived 
trust on the part of health- care professionals can be as complex a 
matter as it is on the part of the patient; with regard to mindfulness, 
they suggest that expertise in identifying and dealing with a partic-
ular medication issue, as well as a preoccupation with failure, may 
reside with either or both parties.
I went to [the GP] and I said, I think [my medicines are] 
contradicting with each other. […] He said, no, I’m the 
doctor, I know about medication, nothing is contra-
dicting, it’s all in your head. […] [Two years later, an-
other GP noticed that this participant had a high blood 
pressure]. […] 226 over 126. He checked it six times. 
Going through my medication […] he says, do you know 
what? This, this and this […] contradict with each other. 
 [Mental health conditions group]
I get my bloods done every 13 weeks. [When the result] 
comes back it tells not only me but [also my doctor] 
how my medication is doing. [If the results are outside 
the expected range] my doctor tends then to ask me 
do I want to [adjust] my medication. […] [So] the onus 
is not just on the doctor […], it’s on yourself as well. 
 [Transgender group]
GPs and pharmacists [might have to ask], does this 
[patient] genuinely know [about their medicines] 
or are they flannelling it? Are they pretending to 
know? Because that can be as dangerous, can’t it? 
  [Visually impaired interview]
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4  | DISCUSSION
Our findings illustrate that patients could potentially contribute to 
the “mindfulness” of medicines management. This potential is re-
alized through 4 interacting processes: assimilating and applying 
knowledge about medication risks; communicating with health- care 
professionals; using artefacts; and recognizing the level of trust that 
can be placed in each of the parties involved. Conversely, a weak-
ness or absence of these processes will limit the contribution that a 
patient can make. Also, while these processes contribute to mindful 
organizing, they are in turn informed and shaped by the mindful or-
ganizing that occurs.
Given that mindful organizing is considered to be grounded in 
social interactions and serves to improve understanding of on- going 
risks, it would appear to lend itself to the examination of patient in-
volvement in safety. However, some conceptual issues arise in rela-
tion to our study findings. First, as described in the previous section, 
trust can operate in various ways. In general terms—at least, with 
regard to health- care professionals and their own managers—there 
appears to be a positive relationship between trust and mindful orga-
nizing,22 and a high level of trust has been found to enhance the re-
lationship between mindful organizing and medication error rates.45 
A further consideration, though, is the argument by Entwistle & 
Quick46 that a patient may place trust in a health- care professional 
having considered, and remaining vigilant to, patient safety risks (ie 
mindfully); alternatively, the patient may do so in ignorance of any 
such risks (ie mindlessly). Entwistle & Quick also use the example 
of a patient challenging a health- care professional to illustrate that 
a given behaviour could be indicative of high trust (eg in the belief 
that the 2 are working together to anticipate any patient safety risks) 
or low trust (eg in the belief that low competence on the part of the 
health- care professional will be exposed). It might be surmised that 
a health- care professional reacts differently to a patient’s challenge 
based on the perceived level of trust that the patient is demonstrat-
ing, or that there might be individual differences between clinicians 
regarding their openness to being questioned, hence an apparent at-
tempt at mindful organizing having different outcomes. There would 
appear to be merit in examining in more detail how trust and mindful 
organizing influence each other, for example by examining how lev-
els and targets of trust change as an organization becomes more or 
less mindful, as in Roberts et al’s case study.21
A second issue is the intentionality of mindful organizing. 
Levinthal & Rerup47 depict mindful behaviour as being conscious 
and effortful, as opposed to less mindful behaviour which is auto-
matic and routinized; if this depiction holds, as Vogus & Sutcliffe22 
argue that it does, then a question arises as to what was intended by 
the patient behaviours described in the current study. It would seem 
that many of the behaviours were intended to help ensure safe med-
ication usage; possibly they were knowingly motivated by particular 
aspects of mindful organizing (eg a concern about potential failures). 
Whether they were explicitly intended to achieve mindful organizing 
per se, though, is less clear; none of the participants stated this to 
be the case. How important, then, is it for patients and health- care 
providers to engage in mindful organizing in the sense that we have 
defined it here? We would argue that this concept provides a way of 
understanding what patients could do to contribute to patient safety, 
with support from health- care providers as necessary, as opposed to 
what they are currently observed to do. Alternatively, echoing the 
argument made by Hopkins,48 it provides a model against which ob-
served patient involvement in safety can potentially be compared. 
However, we also note the argument made previously47 that while 
mindful organizing needs conscious effort, its role may be to inter-
act with, rather than completely replace, less mindful routinized 
behaviour that presumably can be sustained with less effort on a 
day- to- day basis. In fact, if mindful organizing is held to be effortful, 
excessive reliance on health- care professionals to provide it may be 
undesirable or even counterproductive given the burdens already 
imposed by their work.49
Our findings provide additional insight into the circumstances 
under which patient involvement occurs. Applying the notion of 
mindful organizing highlights the importance of considering how 
patients’ actions interact with other parts (human or artefact) of 
the medicines management system. In other words, the extent to 
which patient action or inaction contributes to medication safety 
depends on the extent to which it complements other risk controls 
present in the system. Mindful organizing on the part of patients 
can compensate to a degree for a lack of mindful organizing on the 
part of health- care providers and therefore is beneficial in its own 
right. However, a lack of reciprocation of, or support for, a patient’s 
efforts in mindful organizing could lead to them being undermined 
or thwarted, possibly without either party realizing this is the case. 
Alternatively, these efforts may be successful in mitigating risks but, 
if the patient’s work is unseen, the risks themselves may remain ob-
scured too; hence, the system is assumed to be safer than it actually 
is. Therefore, patient involvement should not be treated simply as an 
independent safety intervention, and nor should it be assumed or 
expected to occur of its own accord; rather, it should be treated as a 
deliberate strategy to be integrated with other safety- related activi-
ties within the medicines management system, as well as depending 
on the interest and ability of individual patients.34,50
A mindful organizing approach to involving patients in safety 
might, though, raise some issues in implementation. As mindful orga-
nizing serves to amplify signals of potential risks, one issue concerns 
the need for a way to distinguish those signals that accurately point 
to risks from those that are irrelevant.23 Another issue concerns the 
foundation of mindful organizing on tight social coupling around a 
set of core values.42 Previous studies have noted that patient safety 
is not objective but contingent and negotiable between the different 
parties involved.37,40 In which case, how are the core values regarding 
patient safety agreed between patients and health- care profession-
als? It is difficult to provide any definitive answers to these issues on 
the basis of our current data. We surmise that they might be resolved 
between patients and health- care professionals—at least in part—on 
the basis of the factors identified in this study (eg as they develop 
mutual knowledge about risks and trust in each other’s judgement). 
At a broader level, a mindful organizing approach may be supported 
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by particular norms and practices within health- care organizations, for 
example, ones that foster knowledge, information sharing, divergent 
thinking and a repertoire of skills to deal with various situations.21,42,51 
Similar suggestions have been made from a resilience perspective52-54; 
particularly relevant to the current study, Schubert et al.54 discuss 
the importance of incorporating patients and families into the pool of 
distributed and co- operative expertise that is applied to patient care. 
In practical terms, we suggest that mindful organizing would be sup-
ported by, amongst other things, an agreed set of expectations be-
tween health- care professionals and patients, and by the provision of 
tools, processes and infrastructure to support patients in understand-
ing and communicating about safety issues. The working relationship 
is likely to be one that is founded on mutual trust but that allows the 
parties involved to question and modify their collective work as nec-
essary. Incidentally, returning to Levinthal and Rerup’s previously cited 
observation, it might be the case that artefacts of the kind mentioned 
in our study data (e.g. information repositories or medication design 
features) could serve to aid the work of mindful organizing.
With regard to methodology, the current study builds upon previ-
ous research on patient involvement in medication safety by focusing 
on primary care; it also includes insights from a large and diverse sam-
ple of service users, including participants from traditionally “underrep-
resented” demographic groups. The use of focus groups and interviews 
allowed for in- depth exploration of the issues raised by participants. 
However, the study is limited by the nature of the sampling and data col-
lection, which meant that we were unable to corroborate participants’ 
accounts either by consulting the health- care professionals involved or 
by obtaining first- hand observational data of similar encounters.
In simple terms, the implications of our findings echo those of 
other studies, in highlighting the importance for patient of involve-
ment of communication and collaboration between patients and 
health- care professionals.55-57 Our findings further suggest that 
mindful organizing could be a useful concept for understanding how 
patients can aid collective comprehension of patient safety risks. We 
have suggested factors that relate to patients’ engagement in mind-
ful organizing, and which therefore would be usefully developed 
amongst patients in their interactions with health- care professionals.
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